natgillin/translations-raw huggingface dataset:
It is therefore appropriate, to introduce the possibility to prolong the marketing deadline for biocidal products containing such substances, in the product type concerned, provided interested operators submit complete dossiers well before 1 September 2006.
Zato je primerno, da se uvede možnost podaljšanja rokov za dajanje v promet biocidnih proizvodov, ki vsebujejo take snovi v zadevni vrsti proizvoda, v kolikor bodo zainteresirani gospodarski subjekti predložili popolne dosjeje precej pred 1. septembrom 2006.
If these dossiers are accepted, an extension of the period for placing those products on the market in the product types concerned should be allowed until the end of the evaluation of the complete dossiers, which should take place in parallel with the evaluation of the notified substances for the product types concerned.
Če se ti dosjeji sprejmejo, je treba dovoliti podaljšanje obdobja za dajanje v promet navedenih proizvodov v zadevnih vrstah proizvodov do konca ocenjevanja popolnih dosjejev, ki mora potekati vzporedno z ocenjevanjem prijavljenih snovi za zadevne vrste proizvodov.
The task of evaluation should be distributed among the competent authorities of all Member States.
Naloga ocenjevanja mora biti porazdeljena med pristojne organe vseh držav članic.
Annex V to Regulation (EC) No 2032/2003 so far only designates the Rapporteur Member States for certain active substance/product type combinations.
V Prilogi V k Uredbi (ES) št. 2023/2003 so zaenkrat imenovane le države članice poročevalke za določene kombinacije aktivnih snovi/vrst proizvodov.
It is therefore necessary to designate the Rapporteur Member States for the remaining product types, taking into account also the accession of the new Member States on 1 May 2004.
Zato je treba imenovati države članice poročevalke za preostale vrste proizvodov, pri čemer je treba upoštevati tudi pristop novih držav članic 1. maja 2004.
The list of competent authorities should also be adapted accordingly.
Ustrezno je treba prilagoditi tudi seznam pristojnih organov.
Economic operators have expressed an interest in taking over the role of participants following the publication by the Commission of those cases where for a given active substance/product type combination, all participants have withdrawn or have failed to comply with their obligations.
Gospodarski subjekti so izrazili zanimanje, da bi prevzeli vlogo udeležencev, ko Komisija objavi primere, v katerih so se za zadevno kombinacijo aktivne snovi/vrste proizvoda vsi udeleženci umaknili ali niso izpolnili svojih obveznosti.
This has happened for three substances and it is therefore appropriate to list those substances, together with the designated Rapporteur Member States and the new deadlines for submission of the complete dossiers in a separate Annex.
To se je zgodilo v primeru treh snovi in zato je primerno, da se te snovi navede v posebni prilogi, skupaj z imenovanimi državami članicami poročevalkami in novimi roki za predložitev popolnih dosjejev.
For a number of notified existing active substances/product type combinations — in particular those notified for product types 8 and 14 — all participants have withdrawn or not complied with their obligations, and no other economic operator or Member State has expressed an interest to take over the role of participants within the given deadlines.
Za več prijavljenih kombinacij obstoječih aktivnih snovi/vrst proizvodov — zlasti tistih, prijavljenih za vrste proizvodov 8 in 14 — so se vsi udeleženci umaknili ali niso izpolnili svojih obveznosti in noben drug gospodarski subjekt ali država članica ni v danih rokih izrazila zanimanja za prevzem vloge udeleženca.
Furthermore, following the recent classification by the competent authorities and the Commission of certain milk hygiene products as biocidal products in product type 3 as defined in Annex V to Directive 98/8/EC, it is appropriate to include into Annex II certain substances used in those milk hygiene products where producers, formulators or associations believing that these were not concerned by Directive 98/8/EC did not submit notifications before the deadlines established by Regulations (EC) No 1896/2000 and (EC) No 1687/2002, but have done so before the adoption of this Regulation.
Poleg tega je po tem, ko so pristojni organi in Komisija nedavno uvrstili nekatere proizvode za zagotavljanje higiene mleka kot biocidne pripravke v vrsto proizvodov 3, kot je opredeljena v Prilogi V k Direktivi 98/8/ES, primerno, da se v Prilogo II uvrsti nekatere snovi, uporabljene v navedenih proizvodih za zagotavljanje higiene mleka, za katere proizvajalci, formulatorji in združenja, ki so menili, da te snovi niso predmet Direktive 98/8/ES, niso predložili prijav pred iztekom rokov, določenih z uredbama (ES) 1896/2000 in 1687/2002, so pa to storili pred sprejetjem te uredbe.
Annexes II and III to Regulation (EC) No 2032/2003 should therefore be amended accordingly.
Prilogi II in III k Uredbi (ES) št. 2032/2003 je zato treba ustrezno spremeniti.
Annex V, Parts A, B, C, and D, and Annex VI should also be amended in the light of the provisions contained in this Regulation.
Dele A, B, C in D Priloge V ter Prilogo VI je tudi treba spremeniti glede na določbe, ki jih vsebuje ta uredba.
For one substance listed in Annexes I and II to Regulation (EC) No 2032/2003 an incorrect CAS number and for another one an erroneous common name are indicated.
Za eno snov iz Prilog I in II k Uredbi (ES) št. 2032/2003 je navedena napačna številka CAS in za drugo napačno splošno ime.
Four substances are not listed in Annexes I and III, although they were identified within the deadlines set by Regulation (EC) No 1896/2000.
Štiri snovi niso navedene v Prilogah I in III, čeprav so bile identificirane v rokih, določenih z Uredbo (ES) št. 1896/2000.
This should be rectified.
To je treba popraviti.
Regulation (EC) No 2032/2003 should therefore be amended accordingly.
Uredbo (ES) št. 2032/2003 je treba zato ustrezno spremeniti.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,
Ukrepi, predvideni s to uredbo, so v skladu z mnenjem Stalnega odbora za biocidne pripravke —
Regulation (EC) No 2032/2003 is amended as follows:
Uredba (ES) št. 2032/2003 se spremeni:
The title of Article 3 is replaced by the following:
Naslov člena 3 se nadomesti z naslednjim:
‘Existing Active Substances’.
„Obstoječe aktivne snovi“
In Article 3 the following paragraph 4 is added:
V členu 3 se doda naslednji odstavek 4:
Annex VII contains the list of active substances which were not identified or notified within the time limits laid down in Regulation (EC) No 1896/2000 and Regulation (EC) No 1687/2002 although there is evidence that they were on the market as active substances in biocidal products before 14 May 2000.’
Priloga VII vsebuje seznam aktivnih snovi, ki niso bile identificirane ali prijavljene v rokih, določenih v Uredbi (ES) št. 1896/2000 in Uredbi (ES) št. 1687/2002, čeprav je dokazano, da so bile dane na trg kot aktivne snovi v biocidnih proizvodih pred 14. majem 2000.“
In paragraph 1 the first subparagraph is replaced by the following:
V odstavku 1 se prvi pododstavek nadomesti z naslednjim besedilom:
‘Active substances listed in Annex III and Annex VII shall not be included in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme.’
„Aktivne snovi, navedene v Prilogi III in Prilogi VII, se v okviru programa pregledovanja ne vključijo v Prilogo I, Prilogo IA ali Prilogo IB k Direktivi 98/8/ES.“
In paragraph 2 the first subparagraph is replaced by the following:
V odstavku 2 se prvi pododstavek nadomesti z naslednjim besedilom:
‘Without prejudice to Article 8 of Directive 98/8/EC, the date with effect from which Member States shall, in accordance with Article 16(3) of Directive 98/8/EC, cancel existing authorisations or registrations for biocidal products containing the active substances listed in Annex III and Annex VII, and ensure that such biocidal products are not placed on the market in their territory, shall be 1 September 2006.’
„Ne glede na člen 8 Direktive 98/8/ES je 1. september 2006 datum, s katerim države članice v skladu s členom 16(3) Direktive 98/8/ES prekličejo obstoječa dovoljenja ali registracije za biocidne proizvode, ki vsebujejo aktivne snovi, navedene v Prilogi III in Prilogi VII, in zagotovijo, da se na njihovem ozemlju taki biocidni proizvodi ne dajejo v promet.“
Paragraph 3 is replaced by the following:
Odstavek 3 se nadomesti z naslednjim besedilom:
‘From the date of entry into force of this Regulation, any active substance not listed in Annex I or Annex VII shall be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.’
„Od datuma začetka veljavnosti te uredbe se katera koli aktivna snov, ki ni navedena v Prilogi I ali Prilogi VII, šteje, kakor da ni bila dana v promet za biocidne namene pred 14. majem 2000.“
The following Articles 4a and 4b are inserted:
Vstavita se naslednja člena 4a in 4b:
Essential use
Uporaba bistvenega pomena
Member States may apply to the Commission for an extension of the period laid down in Article 4(2) where they consider that an active substance listed in Annex III or VII is essential for them for reasons of health, safety, protection of cultural heritage or is critical for the functioning of society, and where there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health.
Države članice lahko Komisijo zaprosijo za podaljšanje obdobja, določenega v členu 4(2), kadar menijo, da je aktivna snov iz Priloge III ali VII bistvenega pomena iz zdravstvenih in varstvenih razlogov ter zaradi varovanja kulturne dediščine ali je odločilnega pomena za delovanje družbe in kadar ni na razpolago drugih tehnično in ekonomsko izvedljivih možnosti ali nadomestkov, ki so sprejemljivi z okoljskega in zdravstvenega vidika.
Applications shall be accompanied by a document stating the reasons and justifications.
Vloge mora spremljati dokument, ki navaja utemeljitve in obrazložitve.
The applications referred to in paragraph 1 shall be forwarded by the Commission to the other Member States and be made publicly available by electronic means.
Vloge iz odstavka 1 Komisija posreduje drugim državam članicam in jih preko elektronskih sredstev da na voljo javnosti.
Member States or any person may for a period of 60 days following reception of an application submit comments in writing to the Commission.
Države članice ali katera koli oseba lahko v roku 60 dni po prejemu vloge Komisiji predloži pisne pripombe.
Taking account of the comments received, the Commission may in accordance with Article 16(2) of Directive 98/8/EC grant an extension of the period laid down in Article 4(2) of this Regulation for placing the substance on the market of the requesting Member States until 14 May 2010 at the latest, provided that the Member States:
Ob upoštevanju prejetih pripomb lahko Komisija v skladu s členom 16(2) Direktive 98/8/ES odobri podaljšanje obdobja, določenega v členu 4(2) te uredbe, za dajanje snovi v promet v državi članici prosilki do 14. maja 2010, če države članice:
ensure that continued use is only possible under the conditions that products containing the substance are approved for the intended essential use;
zagotovijo, da je nadaljnja uporaba mogoča le pod pogojem, da so proizvodi, ki vsebujejo snov, odobreni za predvideno uporabo bistvenega pomena;
conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment;
ugotovijo, da je ob upoštevanju vseh razpoložljivih podatkov smiselno domnevati, da nadaljnja uporaba nima nikakršnih nesprejemljivih učinkov na zdravje ljudi ali živali ali na okolje;
impose all appropriate risk reduction measures when granting approval;
ob odobritvi dovoljenj uvedejo vse ustrezne ukrepe za zmanjšanje tveganja;
ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and
zagotovijo, da se odobreni biocidni proizvodi, ki ostanejo v prometu po 1. septembru 2006, na novo označijo, da bi ustrezali pogojem uporabe, ki so jih določile države članice v skladu s tem odstavkom; ter
ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC by 14 May 2008 at the latest.
zagotovijo, da, kadar je to primerno, imetniki dovoljenj ali zadevne države članice iščejo druge možnosti za tovrstne uporabe ali da pripravljajo dosje, ki bo v skladu s postopkom iz člena 11 Direktive 98/8/ES predložen najkasneje do 14. maja 2008.
The Member States concerned shall annually inform the Commission on the application of paragraph 3 and in particular on the actions taken pursuant to point (e).
Zadevne države članice letno obveščajo Komisijo o uporabi odstavka 3 in zlasti o ukrepih, sprejetih v skladu s točko (e).
Member States may at any time review the approvals of biocidal products for which the period of placing on the market has been extended in accordance with paragraph 3.
Države članice lahko kadar koli pregledajo dovoljenja za biocidne proizvode, za katere je bilo obdobje za dajanje v promet podaljšano v skladu z odstavkom 3.
Whenever there is reason to believe that any of the conditions set in points (a) to (e) of that paragraph are no longer satisfied, the Member States concerned shall without undue delay take steps to remedy the situation or if that is not possible, withdraw the approvals of the biocidal products concerned.
Če obstaja razlog za domnevo, da kateri koli od pogojev, določenih v točkah (a) do (e) navedenega odstavka, ni več izpolnjen, zadevne države članice brez nepotrebnega odlašanja sprejmejo ukrepe za izboljšanje stanja ali, če to ni mogoče, odvzamejo dovoljenja za zadevne biocidne proizvode.
Extension of deadline for placing on the market
Podaljšanje roka za dajanje v promet
Producers, formulators, associations or other persons may apply for an extension of the period laid down in Article 4(2) for the marketing of biocidal products containing active substances referred to in that paragraph by submitting a complete dossier for each active substance and product type combination concerned that complies with the requirements of Annex IV to the competent authority in one of the Member States by 1 March 2006 at the latest.
Proizvajalci, formulatorji, združenja in druge osebe lahko zaprosijo za podaljšanje obdobja, določenega v členu 4(2), za dajanje v promet biocidnih proizvodov, ki vsebujejo aktivne snovi iz navedenega odstavka, tako, da pristojnemu organu v eni od držav članic najkasneje do 1. marca 2006 predložijo popoln dosje za vsako aktivno snov in kombinacijo vrste proizvoda, ki izpolnjuje zahteve iz Priloge IV.
The receiving Member State shall verify whether the dossier referred to in paragraph 1 is to be accepted as complete in accordance with Article 9(1) to (4).
Država članica sprejema preveri, ali se dosje iz odstavka 1 lahko sprejme kot popoln v skladu s členom 9(1) do (4).
If the dossier is accepted as complete the active substance/product type combinations shall be included into Annex II and Annex V and, where appropriate, be removed from Annex III or VII.
Če se dosje sprejme kot popoln, se kombinacije aktivnih snovi/vrst proizvodov vključijo v Prilogo II in Prilogo V in po potrebi črtajo iz Priloge III ali IV.
For product types other than 8 and 14, the evaluation of the dossiers shall commence at the same time as the evaluation of dossiers for other active substances in the same product type(s) as specified in Annex V.’
Za vrste proizvodov, razen 8 in 14, se začne ocenjevanje dosjejev istočasno z ocenjevanjem dosjejev za druge aktivne snovi v isti vrsti(-ah) proizvoda(-ov), kot je določeno v Prilogi V.“
In paragraph 2, the following is inserted as third and fourth subparagraphs:
V odstavku 2 se kot tretji in četrti pododstavek vstavi naslednje besedilo:
‘The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 1 to 6 and 13 are specified in part C of Annex V.
„Države članice poročevalke, ki so imenovane za pregled obstoječih aktivnih snovi, navedenih v Prilogi II, za vrste proizvodov 1 do 6 in 13, so določene v delu C Priloge V.
The Rapporteur Member States designated to review existing active substances listed in Annex II in respect of product types 7, 9 to 12, 15, 17, 20, 22 and 23 are specified in part D of Annex V.’
Države članice poročevalke, ki so imenovane za pregled aktivnih snovi, navedenih v Prilogi II, za vrste proizvodov 7, 9 do 12, 15, 17, 20, 22 in 23, so določene v delu D Priloge V.“
In paragraph 4, ‘1 July 2003’ is replaced by ‘1 March 2005’.
V odstavku 4 se datum „1. julija 2003“ nadomesti s „1. marca 2005“.
In Article 7, the following third paragraph is added:
Členu 7 se doda naslednji odstavek:
‘However, any Member State wishing to receive copies only in electronic format or different numbers of copies shall inform the Commission, which shall make that information publicly available by electronic means.
„Če pa želi katera koli država članica prejeti izvode le v elektronski obliki ali različno število izvodov, o tem obvesti Komisijo, ki da navedene informacije preko elektronskih sredstev na voljo javnosti.
If the Member State subsequently decides otherwise, it shall inform the Commission without undue delay, whereupon the Commission shall update accordingly the information made publicly available.’
Če se država članica kasneje odloči drugače, o tem brez nepotrebnega odlašanja obvesti Komisijo, ki nato ustrezno posodobi javno razpoložljive informacije.“
In Article 8(4) the following fourth subparagraph is added:
Členu 8(4) se doda naslednji četrti pododstavek:
‘The active substances concerned, the Rapporteur Member States and the new time periods shall be listed in Annex VIII.
„Zadevne aktivne snovi, države članice poročevalke in novi roki se navedejo v Prilogi VIII.
Annex V shall be updated accordingly.’
Priloga V se ustrezno posodobi.“
Annex II is replaced by the text set out in Annex II to this Regulation.
Priloga II se nadomesti z besedilom iz Priloge II k tej uredbi.
Annex III is amended in accordance with Annex III to this Regulation.
Priloga III se spremeni v skladu s Prilogo III k tej uredbi.
Annex V is amended in accordance with Annex IV to this Regulation.
Priloga V se spremeni v skladu s Prilogo IV k tej uredbi.
Annex VI is replaced by the text set out in Annex V to this Regulation.
Priloga VI se nadomesti z besedilom iz Priloge V k tej uredbi.
The text set out in Annex VI to this Regulation shall be added as Annex VII.
Besedilo iz Priloge VI k tej uredbi se doda kot Priloga VII.
The text set out in Annex VII to this Regulation shall be added as Annex VIII.
Besedilo iz Priloge VII k tej uredbi se doda kot Priloga VIII.
OJ L 228, 8.9.2000, p. 6.
UL L 228, 8.9.2000, str. 6.
Regulation as amended by Regulation (EC) No 2032/2003.
Uredba, kakor je bila spremenjena z Uredbo (ES) št. 2032/2003.
OJ L 258, 26.9.2002, p. 15.
UL L 258, 26.9.2002, str. 15.
Annex I to Regulation (EC) No 2032/2003 is amended as follows:
Priloga I k Uredbe (ES) Št. 2032/2003 se spremeni:
The CAS number for the substance ‘Bacillus sphaericus’ is replaced by ‘143447-72-7’.
Številka CAS za snov „Bacillus sphaericus“ se nadomesti z „143447-72-7“.
The row relating to the substance ‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-tetramethrin’ shall be replaced by the following text:
Vrstica, ki se nanaša na snov „(1,3,4,5,6,7-heksahidro-1,3-diokso-2H-izoindol-2-il)metil(1R-trans)-2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat/d-tetrametrin“ se nadomesti z naslednjim besedilom:
‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-tetramethrin
„(1,3,4,5,6,7-heksahidro-1,3-diokso-2H-izoindol-2-il)metil (1R-trans)-2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat/d-trans-tetrametrin
The following substances are added:
Dodata se naslednji snovi:
Name (EINECS and/or others)
Ime (EINECS in/ali drugi)
EC number
Številka ES
‘Ethinylestradiol
„Etinil estradiol
Tetradecyldimethylbenzylammonium fluoride
Tetradecildimetilbenzilamonijev fluorid
EXISTING ACTIVE SUBSTANCES AND PRODUCT TYPES INCLUDED IN THE REVIEW PROGRAMME [1]
OBSTOJEČE AKTIVNE SNOVI IN VRSTE PROIZVODOV, KI SO VKLJUČENI V PROGRAM PREGLEDOVANJA [1]
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide
2-(2-butoksietoksi)etil 6-propilpiperonil eter/piperonil butoksid
Diphenoxarsin-10-yl oxide
Difenoksarzin-10-il oksid
Benzoic acid
Benzojska kislina
1,3-Dibromo-5,5-dimethylhydantoin
1,3-dibromo-5,5-dimetilhidantoin
2-Chloroacetamide
2-kloroacetamid
Bromoacetic acid
Bromoocetna kislina
Glycollic acid
Glikolska kislina
Peracetic acid
Peroksiocetna kislina
L-(+)-lactic acid
L-(+)-mlečna kislina
Symclosene
Symclosen
Chloroxylenol
Kloroksilenol
Triclocarban
Triklokarban
1,4-Dichlorobenzene
1,4-diklorobenzen
Hexa-2,4-dienoic acid/Sorbic acid
Heksa-2,4-dienojska kislina/sorbinska kislina
Nonanoic acid
Nonanojska kislina
Undecan-2-one/Methyl-nonyl-ketone
Undekan-2-on/metil-nonil-keton
N-(2-Ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide
N-(2-etilheksil)-8,9,10-trinorborn-5-en-2,3-dikarboksimid
1,3-Dichloro-5,5-dimethylhydantoin
1,3-dikloro-5,5-dimetilhidantoin
Benzethonium chloride
Benzetonijev klorid
Cetylpyridinium chloride
Cetilpiridinijev klorid
Octanoic acid
Oktanojska kislina
Sodium dimethylarsinate
Natrijev dimetilarzinat
Tosylchloramide sodium
Tosilkloramid natrij
Potassium dimethyldithiocarbamate
Kalijev dimetilditiokarbamat
Sodium dimethyldithiocarbamate
Natrijev dimetilditiokarbamat
Warfarin sodium
Varfarin natrij
Sodium 2-biphenylate
Natrijev 2-bifenilat
N-(Trichloromethylthio)phthalimide/Folpet
N-(triklormetiltio)ftalimid/folpet
Methyl anthranilate
Metil atranilat
N, N-Diethyl-m-toluamide
N, N-dietil-m-toluamid
Potassium methyldithiocarbamate
Kalijev metilditiokarbamat
Metam-sodium
Metam-natrij
Disodium cyanodithiocarbamate
Dinatrijev cianoditiokarbamat
1,3-Bis(hydroxymethyl)urea
1,3-bis(hidroksimetil)sečnina
Sodium hydrogencarbonate
Natrijev hidrogenkarbonat
Decanoic acid
Dekanojska kislina
Cyanamide
Cianamid
2-Hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one
2-hidroksi-4-izopropil-2,4,6-cikloheptatrien-1-on
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS; 1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio 1: 1:1: 1:1: 1:1: 1)/Allethrin
(RS)-3-alil-2-metil-4-oksociklopent-2-enil-(1RS,3RS; 1RS,3SR)-2,2-dimetil-3-(2-metilprop-1-enil)-ciklopropankarboksilat (vsi izomeri; razmerje: 1:1: 1:1: 1:1: 1:1)/aletrin
Phthalaldehyde
Ftalaldehid
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid
Dikloro-N-[(dimetilamino)sulfonil]fluoro-N-(p-tolil) metansulfenamid/tolifluanid
Hydroxyl-2-pyridone
Hidroksil-2-piridon
2,6-dimethyl-1,3-dioxan-4-yl acetate
2,6-dimetil-1,3-dioksan-4-il acetat
Tetradonium bromide
Tetradonov bromid
(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-tetramethrin
(1,3,4,5,6,7-heksahidro-1,3-diokso-2H-izoindol-2-il)metil (1R-trans)-2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat/d-trans-tetrametrin
4,5-Dichloro-3H-1,2-dithiol-3-one
4,5-dikloro-3H-1,2-ditiol-3-on
Copper oxide
Bakrov oksid
Disodium tetraborate, anhydrous
Dinatrijev tetraborat, brezvodni
Naphthenic acids, copper salts
Naftenske kisline, bakrove soli
2,4-Dichlorobenzyl alcohol
2,4-diklorobenzil alkohol
4-(2-Nitrobutyl)morpholine
4-(2-nitrobutil)morfolin
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine
N-(3-aminopropil)-N-dodecilpropan-1,3-diamin
2,2'-Dithiobis[N-methylbenzamide]
2,2'-ditiobis[N-metilbenzamid]
1,2-Benzisothiazol-3(2H)-one
1,2-benzizotiazol-3(2H)-on
Sulphuryl difluoride
Sulfuril difluorid
Troclosene sodium
Triklosan natrij